|
DE1252898B
(de)
|
1965-06-12 |
1967-10-26 |
Bayer Ag |
Verfahren zur Herstellung von Copolymerisaten des Trioxans
|
|
US5240928A
(en)
|
1989-07-03 |
1993-08-31 |
Merck & Co., Inc. |
Substituted quinazolinones as angiotensin II antagonists
|
|
DE3930262A1
(de)
|
1989-09-11 |
1991-03-21 |
Thomae Gmbh Dr K |
Kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
|
|
CA2037630C
(en)
|
1990-03-07 |
2001-07-03 |
Akira Morimoto |
Nitrogen-containing heterocylic compounds, their production and use
|
|
US5470975A
(en)
|
1990-10-16 |
1995-11-28 |
E.R. Squibb & Sons, Inc. |
Dihydropyrimidine derivatives
|
|
US5290780A
(en)
|
1991-01-30 |
1994-03-01 |
American Cyanamid Co. |
Angiotensin II receptor blocking 2,3,6 substituted quinazolinones
|
|
US5238942A
(en)
|
1991-05-10 |
1993-08-24 |
Merck & Co., Inc. |
Substituted quinazolinones bearing acidic functional groups as angiotensin ii antagonists
|
|
US5202322A
(en)
|
1991-09-25 |
1993-04-13 |
Merck & Co., Inc. |
Quinazolinone and pyridopyrimidine a-II antagonists
|
|
US5532243A
(en)
|
1992-02-14 |
1996-07-02 |
The Dupont Merck Pharmaceutical Company |
Antipsychotic nitrogen-containing bicyclic compounds
|
|
US5358951A
(en)
|
1993-04-23 |
1994-10-25 |
American Cyanamid Company |
Angiotensin II receptor blocking 2, 3, 6 substituted quinazolinones
|
|
DE4407047A1
(de)
|
1994-03-03 |
1995-09-07 |
Merck Patent Gmbh |
Acetamide
|
|
US20010016657A1
(en)
|
1997-03-18 |
2001-08-23 |
Smithkline Beecham P.L.C. |
Substituted isoquinoline derivatives and their use as anticonvulsants
|
|
HUP0102404A2
(hu)
|
1998-02-04 |
2001-11-28 |
Banyu Pharmaceutical Co., Ltd. |
N-acilezett gyűrűs aminszármazékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyászati készítmények
|
|
JP2001039950A
(ja)
|
1999-07-30 |
2001-02-13 |
Banyu Pharmaceut Co Ltd |
Ｎ−アシル環状アミン誘導体
|
|
AU1244001A
(en)
|
1999-10-27 |
2001-05-08 |
Cor Therapeutics, Inc. |
Pyridyl-containing spirocyclic compounds as inhibitors of fibrinogen-dependent platelet aggregation
|
|
CA2440803A1
(en)
|
2001-03-07 |
2002-09-12 |
Pfizer Products Inc. |
Modulators of chemokine receptor activity
|
|
WO2003086288A2
(en)
|
2002-04-12 |
2003-10-23 |
Merck & Co., Inc. |
Bicyclic amides
|
|
GB0303852D0
(en)
|
2003-02-19 |
2003-03-26 |
Pfizer Ltd |
Triazole compounds useful in therapy
|
|
WO2005023762A1
(en)
|
2003-09-04 |
2005-03-17 |
Abbott Laboratories |
Pyrrolidine-2-carbonitrile derivatives and their use as inhibitors of dipeptidyl peptidase-iv (dpp-iv)
|
|
SE0302811D0
(sv)
|
2003-10-23 |
2003-10-23 |
Astrazeneca Ab |
Novel compounds
|
|
GB0324790D0
(en)
|
2003-10-24 |
2003-11-26 |
Astrazeneca Ab |
Amide derivatives
|
|
US7226951B2
(en)
|
2003-12-17 |
2007-06-05 |
Allergan, Inc. |
Compounds having selective cytochrome P450RAI-1 or selective cytochrome P450RAI-2 inhibitory activity and methods of obtaining the same
|
|
JP4845873B2
(ja)
|
2004-03-03 |
2011-12-28 |
ケモセントリックス インコーポレーティッド |
二環式および架橋した窒素複素環
|
|
PT1761542E
(pt)
|
2004-06-09 |
2008-03-26 |
Hoffmann La Roche |
Derivados de octa-hidro-pirrolo[3,4-c) pirrole e o seu uso com agentes antivirais
|
|
JP5031564B2
(ja)
|
2004-08-10 |
2012-09-19 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
Ｈｉｖ抑制１，２，４−トリアジン−６−オン誘導体
|
|
US7410949B2
(en)
|
2005-01-18 |
2008-08-12 |
Hoffmann-La Roche Inc. |
Neuropeptide-2 receptor (Y-2R) agonists and uses thereof
|
|
MX2007013469A
(es)
|
2005-04-28 |
2008-01-22 |
Wyeth Corp |
Forma ii polimorfa de tanaproget.
|
|
US7737279B2
(en)
|
2005-05-10 |
2010-06-15 |
Bristol-Myers Squibb Company |
1,6-dihydro-1,3,5,6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising same
|
|
TW200800999A
(en)
|
2005-09-06 |
2008-01-01 |
Astrazeneca Ab |
Novel compounds
|
|
ES2427989T3
(es)
|
2005-10-28 |
2013-11-05 |
Ono Pharmaceutical Co., Ltd. |
Compuesto que contiene un grupo básico y uso del mismo
|
|
WO2007058322A1
(ja)
|
2005-11-18 |
2007-05-24 |
Ono Pharmaceutical Co., Ltd. |
塩基性基を含有する化合物およびその用途
|
|
WO2007103719A2
(en)
|
2006-03-03 |
2007-09-13 |
Incyte Corporation |
MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME
|
|
JP2008031064A
(ja)
|
2006-07-27 |
2008-02-14 |
Astellas Pharma Inc |
ジアシルピペラジン誘導体
|
|
JP5256202B2
(ja)
|
2006-09-11 |
2013-08-07 |
エム・エス・ディー・オス・ベー・フェー |
キナゾリノンおよびイソキノリノンアセトアミド誘導体
|
|
CA2663500A1
(en)
|
2006-09-15 |
2008-03-20 |
Schering Corporation |
Spiro-condensed azetidine derivatives useful in treating pain, diabetes and disorders of lipid metabolism
|
|
US8735411B2
(en)
|
2006-10-02 |
2014-05-27 |
Abbvie Inc. |
Macrocyclic benzofused pyrimidine derivatives
|
|
EP2097388B1
(en)
|
2006-11-15 |
2011-09-07 |
High Point Pharmaceuticals, LLC |
Novel 2-(2-hydroxyphenyl)benzimidazoles useful for treating obesity and diabetes
|
|
TW200831085A
(en)
|
2006-12-13 |
2008-08-01 |
Merck & Co Inc |
Non-nucleoside reverse transcriptase inhibitors
|
|
EP1975165A1
(de)
|
2007-03-27 |
2008-10-01 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Substituierte Pyrrolidinamide, deren Herstellung und deren Verwendung als Arzneimittel
|
|
EP2142520A1
(en)
|
2007-03-29 |
2010-01-13 |
F. Hoffmann-Roche AG |
Non-nucleoside reverse transcriptase inhibitors
|
|
CL2008001002A1
(es)
|
2007-04-11 |
2008-10-17 |
Actelion Pharmaceuticals Ltd |
Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana.
|
|
EP2152711B1
(de)
|
2007-04-27 |
2010-11-24 |
Sanofi-Aventis |
2 -heteroaryl- pyrrolo [3, 4-c]pyrrol- derivate und deren verwendung als scd inhibitoren
|
|
DE102007047737A1
(de)
|
2007-10-05 |
2009-04-30 |
Merck Patent Gmbh |
Piperidin- und Piperazinderivate
|
|
CA2702984C
(en)
|
2007-10-19 |
2017-04-11 |
Sarcode Corporation |
Compositions and methods for treatment of diabetic retinopathy
|
|
PE20091017A1
(es)
|
2007-10-31 |
2009-07-16 |
Janssen Pharmaceutica Nv |
Diaminas en puente o fusionadas sustituidas con arilo como moduladores de leucotrieno a4 hidrolasa
|
|
JP2009161449A
(ja)
|
2007-12-28 |
2009-07-23 |
Lion Corp |
Ｐｐａｒ活性促進剤並びに美容用飲食品、皮膚外用剤及び医薬
|
|
US20110071129A1
(en)
|
2008-06-19 |
2011-03-24 |
Makoto Ando |
Spirodiamine-diaryl ketoxime derivative
|
|
US8673917B2
(en)
|
2008-09-09 |
2014-03-18 |
Sanofi |
2-heteroaryl-pyrrolo [3,4-C]pyrrole derivatives, and use thereof as SCD inhibitors
|
|
TW201020247A
(en)
|
2008-11-06 |
2010-06-01 |
Gruenenthal Gmbh |
Substituierte disulfonamide
|
|
CN102216273A
(zh)
|
2008-11-17 |
2011-10-12 |
霍夫曼-拉罗奇有限公司 |
用作crth2拮抗剂或部分激动剂的萘乙酸
|
|
DE102008059578A1
(de)
|
2008-11-28 |
2010-06-10 |
Merck Patent Gmbh |
Benzo-Naphtyridin Verbindungen
|
|
AU2009321867B2
(en)
|
2008-12-01 |
2015-12-10 |
Merck Patent Gmbh |
2,5-Diamino-substituted pyrido[4,3-d]pyrimidines as autotaxin inhibitors against cancer
|
|
TW201035102A
(en)
|
2009-03-04 |
2010-10-01 |
Gruenethal Gmbh |
Sulfonylated tetrahydroazolopyrazines and their use as medicinal products
|
|
TW201038572A
(en)
|
2009-03-25 |
2010-11-01 |
Gruenenthal Gmbh |
Substituted spiro-amide compounds
|
|
EP2623491A3
(en)
|
2009-04-02 |
2014-07-30 |
Merck Patent GmbH |
Piperidine and piperazine derivatives as autotaxin inhibitors
|
|
BRPI1009800A2
(pt)
|
2009-04-02 |
2016-03-15 |
Merck Patent Gmbh |
compostos heterocíclicos como inibidores de autotaxina
|
|
CN102369195B
(zh)
|
2009-04-02 |
2014-04-16 |
默克专利有限公司 |
自分泌运动因子抑制剂
|
|
FR2945534B1
(fr)
|
2009-05-12 |
2012-11-16 |
Sanofi Aventis |
DERIVES DE CYCLOPENTAL[c]PYRROLE-2-CARBOXYLATES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
|
|
CN102459249A
(zh)
|
2009-05-22 |
2012-05-16 |
埃克塞里艾克西斯公司 |
作为PI3K/mTOR抑制剂的苯并氧氮杂环庚三烯以及它们使用与制造方法
|
|
US20120083476A1
(en)
|
2009-06-05 |
2012-04-05 |
Janssen Pharmaceutica Nv |
Heteroaryl-substituted spirocyclic diamine urea modulators of fatty acid amide hydrolase
|
|
DE102009033392A1
(de)
*
|
2009-07-16 |
2011-01-20 |
Merck Patent Gmbh |
Heterocyclische Verbindungen als Autotaxin-Inhibitoren II
|
|
IN2012DN00754A
(enExample)
|
2009-08-04 |
2015-06-19 |
Amira Pharmaceuticals Inc |
|
|
UA107360C2
(en)
|
2009-08-05 |
2014-12-25 |
Biogen Idec Inc |
Bicyclic aryl sphingosine 1-phosphate analogs
|
|
AR079022A1
(es)
|
2009-11-02 |
2011-12-21 |
Sanofi Aventis |
Derivados de acido carboxilico ciclico sustituidos con acilamino, su uso como productos farmaceuticos, composicion farmaceutica y metodo de preparacion
|
|
KR20120112755A
(ko)
|
2010-01-07 |
2012-10-11 |
이 아이 듀폰 디 네모아 앤드 캄파니 |
살진균제 복소환 화합물
|
|
WO2011115813A1
(en)
|
2010-03-18 |
2011-09-22 |
Abbott Laboratories |
Lactam acetamides as calcium channel blockers
|
|
SG183812A1
(en)
|
2010-03-19 |
2012-10-30 |
Pfizer |
2,3 dihydro-1h-inden-1-yl- 2,7-diazaspiro [3.5] nonane derivatives and their use as antagonists or inverse agonists of the ghrelin receptor
|
|
EP2552914B1
(de)
|
2010-03-26 |
2015-11-11 |
Merck Patent GmbH |
Benzonaphthyridinamine als autotaxin-inhibitoren
|
|
GB201008005D0
(en)
|
2010-05-13 |
2010-06-30 |
Sentinel Oncology Ltd |
Pharmaceutical compounds
|
|
WO2011151461A2
(en)
*
|
2010-06-04 |
2011-12-08 |
B.S.R.C. "Alexander Fleming" |
Autotaxin pathway modulation and uses thereof
|
|
AR082590A1
(es)
|
2010-08-12 |
2012-12-19 |
Hoffmann La Roche |
Inhibidores de la tirosina-quinasa de bruton
|
|
EP2606031B1
(en)
*
|
2010-08-20 |
2017-09-27 |
Amira Pharmaceuticals, Inc. |
Autotaxin inhibitors and uses thereof
|
|
ES2530345T3
(es)
|
2010-09-02 |
2015-03-02 |
Merck Patent Gmbh |
Derivados de pirazolopiridinona como antagonistas del receptor del LPA
|
|
JP5937102B2
(ja)
|
2010-12-14 |
2016-06-22 |
エレクトロフォレティクス リミテッド |
カゼインキナーゼ１デルタ（ｃｋ１デルタ）阻害剤
|
|
WO2012166415A1
(en)
|
2011-05-27 |
2012-12-06 |
Amira Pharmaceuticals, Inc. |
Heterocyclic autotaxin inhibitors and uses thereof
|
|
ES2609579T3
(es)
|
2011-08-29 |
2017-04-21 |
VIIV Healthcare UK (No.5) Limited |
Derivados espiro de diamina bicíclica como inhibidores de la unión del VIH
|
|
WO2013054185A1
(en)
|
2011-10-13 |
2013-04-18 |
Pfizer, Inc. |
Pyrimidine and pyridine derivatives useful in therapy
|
|
JPWO2013065712A1
(ja)
|
2011-10-31 |
2015-04-02 |
東レ株式会社 |
ジアザスピロウレア誘導体及びその医薬用途
|
|
US8809552B2
(en)
|
2011-11-01 |
2014-08-19 |
Hoffmann-La Roche Inc. |
Azetidine compounds, compositions and methods of use
|
|
US9815851B2
(en)
|
2011-12-02 |
2017-11-14 |
Phenex Pharmaceuticals Ag |
Pyrrolo carboxamides as modulators of orphan nuclear receptor RAR-related orphan receptor-gamma (RORγ, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune diseases
|
|
TWI638802B
(zh)
|
2012-05-24 |
2018-10-21 |
芬蘭商奧利安公司 |
兒茶酚ｏ－甲基轉移酶活性抑制化合物
|
|
US9611267B2
(en)
|
2012-06-13 |
2017-04-04 |
Incyte Holdings Corporation |
Substituted tricyclic compounds as FGFR inhibitors
|
|
HRP20161774T1
(hr)
|
2012-06-13 |
2017-02-24 |
F. Hoffmann - La Roche Ag |
Novi diazaspirocikloalkan i azaspirocikloalkan
|
|
ES2668694T3
(es)
|
2012-07-27 |
2018-05-21 |
Biogen Ma Inc. |
Derivados de ácido 1-[7-(cis-4-metil-ciclohexiloxi)-8-trifluorometil-naftalen-2-ilmetil]-piperidin-4-carboxílico como moduladores de autotaxina (ATX) para tratar inflamaciones y trastornos autoinmunitarios
|
|
NZ703851A
(en)
|
2012-07-27 |
2017-01-27 |
Biogen Ma Inc |
Compounds that are s1p modulating agents and/or atx modulating agents
|
|
BR112015004111A2
(pt)
|
2012-09-25 |
2017-07-04 |
Hoffmann La Roche |
novos derivados bicíclicos
|
|
MY183969A
(en)
|
2012-09-25 |
2021-03-17 |
Bayer Pharma AG |
Combination of regorafenib and acetylsalicylic acid for treating cancer
|
|
AR092742A1
(es)
|
2012-10-02 |
2015-04-29 |
Intermune Inc |
Piridinonas antifibroticas
|
|
DK2912019T3
(da)
|
2012-10-25 |
2021-05-25 |
Tetra Discovery Partners Llc |
Heteroarylhæmmere af pde4
|
|
US20160002247A1
(en)
|
2013-03-01 |
2016-01-07 |
The University Of Tokyo |
8-substituted imidazopyrimidinone derivative having autotaxin inhibitory activity
|
|
AR095079A1
(es)
|
2013-03-12 |
2015-09-16 |
Hoffmann La Roche |
Derivados de octahidro-pirrolo[3,4-c]-pirrol y piridina-fenilo
|
|
TWI593692B
(zh)
|
2013-03-12 |
2017-08-01 |
美國禮來大藥廠 |
四氫吡咯并噻嗪化合物
|
|
WO2014139324A1
(en)
|
2013-03-12 |
2014-09-18 |
Abbvie Inc. |
Tetracyclic bromodomain inhibitors
|
|
EA201591535A1
(ru)
|
2013-03-12 |
2016-04-29 |
Акусела Инк. |
Замещенные производные 3-фенилпропиламина для лечения офтальмологических заболеваний и расстройств
|
|
TW201446768A
(zh)
*
|
2013-03-15 |
2014-12-16 |
Biogen Idec Inc |
S1p及/或atx調節劑
|
|
MX368059B
(es)
|
2013-07-18 |
2019-09-18 |
Novartis Ag |
Inhibidores de autotaxina que comprenden un núcleo de anillo heteroaromático de bencil-amida cíclica.
|
|
WO2015058031A1
(en)
|
2013-10-17 |
2015-04-23 |
Vertex Pharmaceuticals Incorporated |
Dna-pk inhibitors
|
|
EP3878848A1
(en)
|
2013-11-22 |
2021-09-15 |
Sabre Therapeutics LLC |
Autotaxin inhibiting indole compounds
|
|
KR20160087900A
(ko)
|
2013-11-26 |
2016-07-22 |
에프. 호프만-라 로슈 아게 |
신규한 옥타하이드로-사이클로부타[1,2-c；3,4-c'']다이피롤-2-일
|
|
AR098475A1
(es)
|
2013-11-26 |
2016-06-01 |
Bayer Cropscience Ag |
Compuestos pesticidas y usos
|
|
SI3122750T1
(sl)
|
2014-03-26 |
2019-12-31 |
F. Hoffmann-La Roche Ag |
Biciklične spojine kot zaviralci proizvodnje avtotaksina (ATX) in lizofosfatidne kisline (LPA)
|
|
US9815798B2
(en)
|
2014-03-26 |
2017-11-14 |
Basf Se |
Substituted [1,2,4]triazole and imidazole compounds as fungicides
|
|
JO3512B1
(ar)
|
2014-03-26 |
2020-07-05 |
Astex Therapeutics Ltd |
مشتقات كينوكسالين مفيدة كمعدلات لإنزيم fgfr كيناز
|
|
KR20160128428A
(ko)
|
2014-03-26 |
2016-11-07 |
에프. 호프만-라 로슈 아게 |
오토탁신(atx) 및 리소포스파티드산(lpa) 생성 억제제로서의 축합형 [1,4]다이아제핀 화합물
|
|
SG11201607920RA
(en)
|
2014-04-04 |
2016-10-28 |
X Rx Inc |
Substituted spirocyclic inhibitors of autotaxin
|
|
BR112017007460A2
(pt)
|
2014-10-14 |
2017-12-19 |
Vitae Pharmaceuticals Inc |
inibidores de di-hidropirrolopiridina de ror-gama
|
|
WO2016128529A1
(en)
|
2015-02-15 |
2016-08-18 |
F. Hoffmann-La Roche Ag |
1-(het)arylsulfonyl-(pyrrolidine or piperidine)-2-carboxamide derivatives and their use as trpa1 antagonists
|
|
MA41898A
(fr)
|
2015-04-10 |
2018-02-13 |
Hoffmann La Roche |
Dérivés de quinazolinone bicyclique
|
|
CN104927727B
(zh)
|
2015-07-06 |
2017-01-11 |
香山红叶建设有限公司 |
一种玻璃幕墙用结构密封胶及其制备方法
|
|
PL415078A1
(pl)
|
2015-09-04 |
2017-03-13 |
Oncoarendi Therapeutics Spółka Z Ograniczoną Odpowiedzialnością |
Podstawione aminotriazole przydatne jako inhibitory kwaśnej chitynazy ssaków
|
|
JP6886967B2
(ja)
|
2015-09-04 |
2021-06-16 |
エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ |
フェノキシメチル誘導体
|
|
AU2016328365B2
(en)
|
2015-09-24 |
2020-04-23 |
F. Hoffmann-La Roche Ag |
New bicyclic compounds as dual ATX/CA inhibitors
|
|
CN107635995B
(zh)
|
2015-09-24 |
2022-08-19 |
豪夫迈·罗氏有限公司 |
作为atx抑制剂的二环化合物
|
|
SG10201913209WA
(en)
|
2015-09-24 |
2020-02-27 |
Ionis Pharmaceuticals Inc |
Modulators of kras expression
|
|
RU2018112230A
(ru)
|
2015-09-24 |
2019-10-30 |
Ф. Хоффманн-Ля Рош Аг |
Бициклические соединения в качестве ингибиторов atx
|
|
JP6877413B2
(ja)
|
2015-09-24 |
2021-05-26 |
エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ |
二重ａｔｘ／ｃａ阻害剤としての新規な二環式化合物
|
|
CR20180336A
(es)
|
2015-11-25 |
2018-08-06 |
Dana Farber Cancer Inst Inc |
Inhibidores de bromodominio bivalentes y usos de los mismos
|
|
CA3006029C
(en)
|
2015-12-01 |
2020-08-04 |
Nihon Nohyaku Co., Ltd. |
3h-pyrrolopyridine compound, n-oxide thereof or salt thereof, agricultural and horticultural insecticide comprising the compound and method for using the same
|
|
WO2017139978A1
(zh)
|
2016-02-19 |
2017-08-24 |
吴伟东 |
手机app更新方法及系统
|
|
WO2018167113A1
(en)
|
2017-03-16 |
2018-09-20 |
F. Hoffmann-La Roche Ag |
New bicyclic compounds as atx inhibitors
|
|
EP3596059B1
(en)
|
2017-03-16 |
2024-04-24 |
F. Hoffmann-La Roche AG |
Heterocyclic compounds useful as dual atx/ca inhibitors
|
|
PT3448859T
(pt)
|
2017-03-20 |
2019-10-25 |
Forma Therapeutics Inc |
Composições de pirrolopirrole como ativadores de piruvato quinase (pkr).
|